Analysis of saturation binding and saturation infection for dengue serotypes 1 and 2 in liver cells

Intervirology

Volumn 46, Issue 1, 2003, Pages 50-55

  Suksanpaisan, Lukkana ^a   Smith, Duncan R ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Binding; Dengue virus; Receptor; Saturation

Indexed keywords

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL INTERACTION; CELL STRAIN HEPG2; CELL SURFACE; CONTROLLED STUDY; DENGUE VIRUS; HUMAN; HUMAN CELL; INCUBATION TIME; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; VERO CELL; VIRUS ADSORPTION; VIRUS TITRATION;

ANIMALS; CERCOPITHECUS AETHIOPS; DENGUE VIRUS; HUMANS; LIVER; SEROTYPING; TUMOR CELLS, CULTURED; VERO CELLS;

DENGUE VIRUS;

EID: 0037267973     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000068125     Document Type: Article

References (21)

1. Gubler DJ: Dengue and dengue hemorrhagic fever: Its history and resurgence as a global public health problem; in Gubler DJ, Kuno G (eds): Dengue and Dengue Hemorrhagic Fever. Wallingford, CAB International, 1997, pp 1-22.
2. Gubler DJ, Clark GG: Dengue/dengue hemorrhagic fever: The emergence of a global health problem. Emerg Infect Dis 1995;1:55-57.
3. Rigau-Perez JG, Clark GG, Gubler DJ, Reiter P, Sanders EJ, Vorndam AV: Dengue and dengue haemorrhagic fever. Lancet 1998;352:971-976.
4. Halstead SB: Antibody, macrophages, dengue virus infection, shock and hemorrhage: A pathogenetic cascade. Rev Infect Dis 1989;11(suppl 4):S830-S839.
5. Pinheiro FP, Corber SJ: Global situation of dengue and dengue hemorrhagic fever, and its emergence in the Americas. World Health Stat Q 1997;50:161-169.
6. World Health Organisation: Dengue Hemorrhagic Fever: Diagnosis, Treatment and Control. Geneva, World Health Organisation, 1986, pp 7-15.
7. Kuo CH, Tai DI, Chang-Chien CS, Lan CK, Chiou SS, Liaw YF: Liver biochemical tests and dengue fever. Am J Trop Med Hyg 1992;47:265-270.
8. Edelman RS, Nimmannitya S, Colman RW, Talamo RC, Top FH Jr: Evaluation of the plasma kinin system in dengue hemorrhagic fever. J Lab Clin Med 1975;86:410-421.
9. Bhamarapravati N, Tuchinda P, Boonyapaknavik V: Pathology of Thailand haemorrhagic fever: A study of 100 autopsy cases. Ann Trop Med Parasitol 1967;61:500-510.
10. Rosen L, Khin MM, U T: Recovery of virus from the liver of children with fatal dengue: Reflections on the pathogenesis of the disease and its possible analogy with that of yellow fever. Res Virol 1989;140:351-360.
11. Morens DM: Antibody-dependent enhancement of infection and the pathogenesis of viral disease. Clin Infect Dis 1994;19:500-512.
12. Halstead SB: Pathogenesis of dengue: Challenges to molecular biology. Science 1998;239:476-481.
13. Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, Suntayakorn S, Endy TP, Raengsakulrach B, Rothman AL, Ennis FA, Nisalak A: Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 2000;181:2-9.
14. Anderson R, King AD, Innis BL: Correlation of E protein binding with cell susceptibility to dengue 4 virus infection. J Gen Virol 1992;73:2155-2159.
15. Chen Y, Maguire T, Marks RM: Demonstration of binding of dengue virus envelope protein to target cells. J Virol 1996;70:8765-8772.
16. Bielefeldt-Ohmann H: Analysis of antibody-independent binding of dengue viruses and dengue virus envelope protein to human myelomonocytic cells and B lymphocytes. Virus Res 1998;57:63-79.
17. Chen Y, Maguire T, Hileman RE, Fromm JR, Esko D, Linhardt RJ, Marks RM: Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat Med 1997;3:866-871.
18. Putnak JR, Kanesa-Thasan N, Innis BL: A putative cellular receptor for dengue viruses. Nat Med 1997;3:828-829.
19. Karger A, Mettenleiter TC: Identification of cell surface molecules that interact with pseudorabies virus. J Virol 1996;70:2138-2145.
20. Marianneau P, Megret F, Olivier R, Morens DM, Deubel V: Dengue 1 virus binding to human hepatoma HepG2 and simian Vero cell surfaces differs. J Gen Virol 1996;77:2547-2554.
21. Hilgard P, Stockert R: Heparan sulfate proteoglycans initiate dengue virus infection of hepatocytes. Hepatology 2000;32:1069-1077.